Towards Healthcare Research & Consulting
Sickle Cell Anemia Testing and Screening Market
Updated Date: 23 April 2026   |   Report Code: 6612

Sickle Cell Anemia Testing and Screening Market Shaped by Early Diagnosis Demand

Sickle Cell Anemia Testing and Screening Market ( By Technology: Hemoglobin Electrophoresis, High-Performance Liquid Chromatography, Other Tests; By Age Group: Newborn Screening, Adult Screening, Other Age Groups; By Sector Type: Government Labs, Private Labs, Corporate Labs, PPP; By Region: North America, Asia Pacific, Europe, Latin America, Middle East and Africa) Global Analysis, Size, Trends, Leading Companies, Regional Outlook and Forecast 2026 to 2035.

Last Updated : 23 April 2026 Category: Diagnostics Insight Code: 6612 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Global Sickle Cell Anemia Testing and Screening Market Analysis, By Technology
    • Market Size, Forecast & CAGR, By Technology, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Sickle Cell Anemia Testing and Screening Market Analysis, By Age Group
    • Market Size, Forecast & CAGR, By Technology, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Sickle Cell Anemia Testing and Screening Market Analysis, By Sector Type
    • Market Size, Forecast & CAGR, By Technology, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Global Sickle Cell Anemia Testing and Screening Market Analysis, By Region
    • Market Size, Forecast & CAGR, By Technology, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Sickle Cell Anemia Testing and Screening Market Analysis
  • North America Sickle Cell Anemia Testing and Screening Market Analysis, By Technology, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Sickle Cell Anemia Testing and Screening Market Analysis, By Age Group, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Sickle Cell Anemia Testing and Screening Market Analysis, By Sector Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • North America Sickle Cell Anemia Testing and Screening Market Analysis, By Country, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
      • U. S. Sickle Cell Anemia Testing and Screening Market Analysis
    • U. S. Sickle Cell Anemia Testing and Screening Market Analysis, By Technology, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Sickle Cell Anemia Testing and Screening Market Analysis, By Age Group, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
    • U. S. Sickle Cell Anemia Testing and Screening Market Analysis, By Sector Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Similar Analysis will be given for each country and each region

  • Canada
  • Mexico
  • Rest of North America

Europe

  • Western Europe
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Netherlands
  • Switzerland
  • Nordic Countries
  • Rest of Western Europe
  • Eastern Europe
  • Austria
  • Russia & Belarus
  • Poland
  • Türkiye
  • Rest of Eastern Europe

Asia Pacific

  • China
  • Taiwan
  • India
  • Japan
  • Vietnam
  • Australia and New Zealand
  • ASEAN Countries
  • South Korea
  • Rest of APAC

South America

  • Brazil
  • Argentina
  • Rest of South America

Middle East and Africa (MEA)

  • GCC Countries
  • South Africa
  • Egypt
  • Rest of MEA

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Technology
      • By Age Group
      • By Sector Type
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Request A Test, Ltd
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • HALCYON BIOMEDICAL INCORPORATED
    • HemoType
    • Silver Lake Research Corporation
    • Hemex Health
    • Bio-Rad Laboratories, Inc.

FAQ's

Answer : The sickle cell anemia testing and screening market holds a valuation of USD 540.74 million as of 2026, and will expand to USD 1516.47 million by 2035, achieving a CAGR of 12.14% between 2026 and 2035.

Answer : North America is currently leading the sickle cell anemia testing and screening market due to advanced healthcare infrastructure, widespread newborn screening programs, and high awareness of early diagnosis.

Answer : Major growth drivers include rising prevalence of sickle cell disease, expansion of mandatory newborn screening programs, increasing awareness of early diagnosis benefits, technological advancements in diagnostics.

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar